PATH Drug Solutions
Seattle, Washington, United States
Purpose
to support the development of an attenuated Plasmodium falciparum sporozoite vaccine to reduce malaria infection, morbidity, and mortality
Division
Global Health
Date
April 2004
Region Served
GLOBAL
Committed amount
$1,429,611
Grant topic
Malaria
Duration (months)
12
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.